EP0705345B1 - Process for the preparation of pyruvic acid - Google Patents
Process for the preparation of pyruvic acid Download PDFInfo
- Publication number
- EP0705345B1 EP0705345B1 EP94919409A EP94919409A EP0705345B1 EP 0705345 B1 EP0705345 B1 EP 0705345B1 EP 94919409 A EP94919409 A EP 94919409A EP 94919409 A EP94919409 A EP 94919409A EP 0705345 B1 EP0705345 B1 EP 0705345B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- catalase
- glycolate oxidase
- reaction
- acid
- lactate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 title claims description 75
- 229940107700 pyruvic acid Drugs 0.000 title claims description 37
- 238000000034 method Methods 0.000 title claims description 30
- 230000008569 process Effects 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title description 6
- 108010062584 glycollate oxidase Proteins 0.000 claims description 77
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 69
- 102000016938 Catalase Human genes 0.000 claims description 63
- 108010053835 Catalase Proteins 0.000 claims description 63
- 238000006243 chemical reaction Methods 0.000 claims description 56
- 239000003054 catalyst Substances 0.000 claims description 42
- 230000000694 effects Effects 0.000 claims description 41
- 239000001301 oxygen Substances 0.000 claims description 37
- 229910052760 oxygen Inorganic materials 0.000 claims description 37
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 36
- 102000004190 Enzymes Human genes 0.000 claims description 35
- 108090000790 Enzymes Proteins 0.000 claims description 35
- 239000007864 aqueous solution Substances 0.000 claims description 20
- 239000000872 buffer Substances 0.000 claims description 19
- 230000000813 microbial effect Effects 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 102100038837 2-Hydroxyacid oxidase 1 Human genes 0.000 claims 4
- 102100038838 2-Hydroxyacid oxidase 2 Human genes 0.000 description 74
- 238000004128 high performance liquid chromatography Methods 0.000 description 37
- 210000004027 cell Anatomy 0.000 description 36
- 229940076788 pyruvate Drugs 0.000 description 34
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 24
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 20
- 229940001447 lactate Drugs 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 241000235058 Komagataella pastoris Species 0.000 description 18
- 230000003647 oxidation Effects 0.000 description 18
- 238000007254 oxidation reaction Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 17
- 239000011768 flavin mononucleotide Substances 0.000 description 14
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 14
- 229940013640 flavin mononucleotide Drugs 0.000 description 14
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 14
- 229940116871 l-lactate Drugs 0.000 description 14
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 241000320412 Ogataea angusta Species 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 229960000686 benzalkonium chloride Drugs 0.000 description 10
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 10
- 230000004151 fermentation Effects 0.000 description 10
- NGSFWBMYFKHRBD-DKWTVANSSA-M sodium;(2s)-2-hydroxypropanoate Chemical compound [Na+].C[C@H](O)C([O-])=O NGSFWBMYFKHRBD-DKWTVANSSA-M 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 8
- 241000219315 Spinacia Species 0.000 description 8
- 235000009337 Spinacia oleracea Nutrition 0.000 description 8
- 108030001056 (S)-2-hydroxy-acid oxidases Proteins 0.000 description 7
- 238000013019 agitation Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 241000228245 Aspergillus niger Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 4
- 239000007836 KH2PO4 Substances 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000010633 broth Nutrition 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000003760 magnetic stirring Methods 0.000 description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 4
- 230000008823 permeabilization Effects 0.000 description 4
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
- CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 3
- 108010025188 Alcohol oxidase Proteins 0.000 description 3
- 239000004251 Ammonium lactate Substances 0.000 description 3
- 229930182843 D-Lactic acid Natural products 0.000 description 3
- 108010022399 L-2-hydroxyacid oxidase Proteins 0.000 description 3
- 108050006365 L-lactate oxidases Proteins 0.000 description 3
- 101100190845 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pmp-1 gene Proteins 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 229940059265 ammonium lactate Drugs 0.000 description 3
- 235000019286 ammonium lactate Nutrition 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 229940022769 d- lactic acid Drugs 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- -1 non-decarboxylating Proteins 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 2
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 2
- 101000641031 Homo sapiens Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000007998 bicine buffer Substances 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229940054269 sodium pyruvate Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000013022 venting Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-M (S)-lactate Chemical compound C[C@H](O)C([O-])=O JVTAAEKCZFNVCJ-REOHCLBHSA-M 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- GKQWYZBANWAFMQ-DKWTVANSSA-M lithium;(2s)-2-hydroxypropanoate Chemical compound [Li+].C[C@H](O)C([O-])=O GKQWYZBANWAFMQ-DKWTVANSSA-M 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical class [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Definitions
- This invention relates to a process for the production of pyruvic acid, where L-lactic acid and oxygen are reacted in an aqueous solution in the presence of catalysts consisting of glycolate oxidase ((S)-2-hydroxy-acid oxidase, EC 1.1.3.15) and catalase (EC 1.11.1.6).
- catalysts consisting of glycolate oxidase ((S)-2-hydroxy-acid oxidase, EC 1.1.3.15) and catalase (EC 1.11.1.6).
- Pyruvic acid has been prepared by the fermentation of various carbon sources (e.g., glucose, yeast extracts and peptone), but these methods usually produce pyruvic acid in low yields (based on added carbon source) and in relatively low concentrations as one component of a mixture of fermentation products. Separation and isolation of pyruvic acid from such complex fermentation broths are generally difficult and expensive to perform.
- carbon sources e.g., glucose, yeast extracts and peptone
- EP 342,984 discloses an enzymatic assay used to determine the concentration of NAD(P)H in a sample.
- the assay uses as a reagent a mixture containing lactate oxidase. This is not the oxidase of the present invention.
- L-lactate oxidase L-lactate: oxygen oxidoreductase, non-decarboxylating, EC 1.1.3.2
- catalyst B. A. Burdick and J. R. Schaeffer Biotech. Lett., Vol. 9, 253-258 (1987)
- L-lactate oxidase (from Pediococcus ) catalyzes the oxidation of L-lactate by oxygen to pyruvate and hydrogen peroxide:
- Glycolate oxidase (S)-2-hydroxy-acid oxidase, EC 1.1.3.15), an enzyme commonly found in leafy green plants and mammalian cells, catalyzes the oxidation of glycolic acid to glyoxylic acid. This same enzyme also catalyzes the oxidation of L-lactic acid to pyruvic acid, with the concomitant production of hydrogen peroxide.
- This invention relates to the preparation of pyruvic acid (or a salt thereof, as explained more fully hereafter) by oxidizing L-lactic acid (or a salt thereof) with oxygen in aqueous solution and in the presence of the two enzyme catalysts glycolate oxidase (e.g., (S)-2-hydroxy-acid oxidase, EC 1.1.3.15) and catalase (e.g., EC 1.11.1.6).
- glycolate oxidase e.g., (S)-2-hydroxy-acid oxidase, EC 1.1.3.15
- catalase e.g., EC 1.11.1.6
- the present invention provides an improved process for the production of pyruvic acid comprising the steps of reacting, in an aqueous solution, L-lactic acid and oxygen in the presence of the enzyme catalyst glycolate oxidase and the enzyme catalyst catalase for a time sufficient to convert the L-lactic acid to pyruvic acid at high yields, wherein the initial concentration of the L-lactic acid is from about 0.1 to about 2.0 M and then recovering the pyruvic acid.
- pyruvic acid and L-lactic acid particularly when referring to an aqueous solution at pH range of 6 to 10 more specifically refer to a highly dissociated state wherein a partially neutralized acid solution is predominantly present as the pyruvate ion and the L-lactate ion, respectively.
- Pyruvic acid is useful as a chemical intermediate in the preparation of fine chemicals, agrochemicals and pharmaceuticals. Therefore it should be further appreciated that for purposes of this invention, the reference to high yields and recovery of pyruvic acid are intended to include as equivalent a process wherein the pyruvic acid is inherently produced as an intermediate to an otherwise useful derivative compound of pyruvic acid at correspondingly high yields.
- pyruvic acid has been prepared via the enzyme-catalyzed oxidation of L-lactic acid in concentrations of up to 0.5 M, and isolated in 96 % yield (98 % purity, sodium salt).
- the high initial concentration of L-lactic acid employed might have been expected to result in substrate inhibition of the glycolate oxidase, which would have limited the reaction rate and/or the final concentration of product.
- a 0.5 M concentration of pyruvic acid might have resulted in product inhibition of the enzyme, again limiting the concentration of product obtained.
- yields of pyruvate as high as 98-99 % can be obtained in unbuffered reactions run with no pH control; all previous examples of enzymatic oxidations of L-lactate have been performed using a buffer, usually phosphate buffer.
- the high yields of pyruvate obtained in the absence of buffer equal or exceed those obtained in the presence of added buffer.
- the preparation of pyruvate in the absence of added buffer allows for a simple isolation of product from a reaction mixture; the catalyst is removed by filtration or centrifugation, leaving an aqueous solution of a pyruvic acid salt that is easily recovered by removal of the water (for example, by stripping of water under reduced pressure, by lyophilization, or the like).
- the whole-cell catalyst is easily recovered for reuse by filtration or centrifugation, while the soluble enzymes cannot be centrifuged out, and filtration results in the loss of much of the soluble glycolate oxidase activity.
- the recovery of reusable enzyme activities for the whole-cell catalysts is extremely high after each catalyst recycle (ca. 95 % or greater), while the measured activity of remaining soluble glycolate oxidase after one reaction is typically 40 % to 60 %.
- the use of glycolate oxidase and catalase attached to or immobilized on an inert support will exhibit many of these same advantages and as such are to be considered equivalent for purposes of this invention.
- the yield of pyruvate is higher, and the production of byproduct acetate is lower, when using either permeabilized catalyst when compared to using soluble glycolate oxidase and catalase as catalyst.
- the H. polymorpha permeabilized-cell catalyst at the same glycolate oxidase concentration as for the soluble enzyme experiment, less acetate (produced by the reaction of byproduct hydrogen peroxide with pyruvate) is formed, even though the concentration of endogenous cellular catalase present in the reaction mixture is half of that in the soluble enzyme reaction.
- the catalytic oxidation of L-lactic acid or a suitable salt thereof is conveniently carried out by contacting the L-lactic acid with a source of molecular oxygen in the presence of an enzyme catalyst which catalyzes the reaction of L-lactic acid with O 2 to form pyruvic acid.
- an enzyme catalyst which catalyzes the reaction of L-lactic acid with O 2 to form pyruvic acid.
- One such catalyst is the enzyme glycolate oxidase (EC 1.1.3.15), also known as glycolic acid oxidase.
- Glycolate oxidase may be isolated from numerous sources well-known to the art (supra).
- the glycolate oxidase used in the reaction should be present in an effective concentration, usually a concentration of about 0.01 to about 1000 IU/mL, preferably about 0.1 to about 10 IU/mL.
- An IU International Unit
- An IU International Unit is defined as the amount of enzyme that will catalyze the transformation of one micromole of substrate per minute. A procedure for the assay of this enzyme is found in I. Zelitch and S. Ochoa, J. Biol. Chem., Vol. 201, 707-718 (1953). This method is also used to assay the activity of recovered or recycled glycolate oxidase.
- glycolate oxidase as a catalyst for the oxidative conversion of L-lactic acid to pyruvic acid are obtained by incorporating into the reaction solution a catalyst for the decomposition of hydrogen peroxide.
- a peroxide-destroying catalyst which is effective in combination with glycolate oxidase is the enzyme catalase (E.C. 1.11.1.6).
- Catalase catalyzes the decomposition of hydrogen peroxide to water and oxygen, and it is believed to improve yields of pyruvic acid in the present process by accelerating the decomposition of the hydrogen peroxide produced along with pyruvic acid in the glycolate oxidase-catalyzed reaction of lactic acid with O 2 .
- the concentration of catalase should be 50 to 50,000 IU/mL, preferably 2,000 to 15,000 IU/mL. It is preferred that the catalase and glycolate oxidase concentrations be adjusted within the above ranges so that the ratio (measured in IU for each enzyme) of catalase to glycolate oxidase is at least about 250:1.
- a microbial cell catalyst which has been utilized in the present invention is a transformant of Hansenula polymorpha (a methylotrophic yeast).
- H. polymorpha having sufficient glycolate oxidase activity have been prepared by inserting the DNA for glycolate oxidase into an expression vector under the control of the formate dehydrogenase (FMD) promoter.
- FMD formate dehydrogenase
- H. polymorpha was transformed with this vector and a strain producing high levels of glycolate oxidase was selected and designated H. polymorpha GO1 (deposited in ARS Patent Culture Collection, under the Northern Regional Research Laboratory accession number: Y-21065, with the U.S.D.A. at Peoria, Illinois).
- H. polymorpha cell catalysts were typically prepared by first growing an inoculum of an H. polymorpha transformant in 500 mL of YPD (Difco), pH 4.4. This culture was then inoculated into a fermenter containing 10 L of Yeast Nitrogen Base (YNB, Difco) without amino acids (14 g), ammonium sulfate (50 g) and methanol (100 g), at pH 5.0. The fermenter was operated for 42.5 hours at 37°C, an agitation rate of 400 rpm, constant pH of 5.0, 40 % dissolved oxygen (controlled), and 2 x 10 5 Pa (14 psig) of air. At the conclusion of the fermentation, 1.0 kg of glycerol was added and the cells harvested by centrifugation, frozen in liquid nitrogen, and stored at -80 °C.
- YNB Yeast Nitrogen Base
- a second microbial cell catalyst which has been utilized in the present invention is a transformant of Pichia pastoris (a methylotrophic yeast) which expresses the glycolate oxidase enzyme from spinach, as well as an endogenous catalase.
- Pichia pastoris a methylotrophic yeast
- Several transformants of P. pastoris having sufficient glycolate oxidase activity been prepared by inserting a DNA fragment containing the spinach glycolate oxidase gene into a P . pastoris expression vector (pHIL-D4) such as to be under control of the methanol inducible alcohol oxidase I promoter, generating the plasmid pMP1.
- pastoris strain GTS115 (NRRL Y-15851) was transformed by plasmid pMP1 and a selection was done as to allow integration of the linearized plasmid pMP1 into the chromosomal alcohol oxidase I locus and replacement of alcohol oxidase gene with glycolate oxidase gene. A pool of such transformants were next selected for maximal number of integrated copies of the expression cassette. A high copy number transformant designated P. pastoris strain GS115-MSP10 was isolated and deposited as NRRL Y-21001.
- P. pastoris cells were typically prepared by growing an inoculum in 100 mL of YNB containing 1 % glycerol. After 48 hours growth at 30 °C, the cells were transferred into a fermenter containing 10 L of media composed of yeast nitrogen base (YNB) without amino acids (134 g), glycerol (100 g), and biotin (20 mg). The fermentation was operated at pH 5.0 (controlled with NH 4 OH), 30 °C, agitation rate of 200 rpm, aeration of 5 slpm, 1.4 x 10 5 Pa (5 psig) of air, and dissolved oxygen maintained at no lower than 50 % saturation.
- YNB yeast nitrogen base
- the cells When glycerol was depleted, the cells were induced to express glycolate oxidase by growth in the same media except that methanol (50 g) was substituted for glycerol. Glycolate oxidase activity during induction was followed by enzyme assay. After 24 hours of induction the cells were harvested following treatment with glycerol (1 kg). Following harvest the cells were frozen in liquid nitrogen and stored at -80 °C.
- H. polymorpha and P. pastoris cell transformants required permeabilization prior to use as catalyst for the oxidation of glycolic acid to glyoxylic acid.
- a variety of known methods of permeabilization were useful for preparing cells with sufficient glycolate oxidase activity (see Felix, H., Anal. Biochemistry, Vol. 120, 211-234, (1982)).
- a suspension of 10 wt % wet cells in 0.1 % (v/v) "TRITON" X - 100/20 mM phosphate buffer (pH 7.0) was mixed for 15 minutes, then frozen in liquid nitrogen, thawed, and washed with 20 mM phosphate/0.1 mM FMN buffer (pH 7.0).
- a second method of permeabilization was performed by mixing a suspension of 10 wt % wet cells in 0.2 % (w/v) benzalkonium chloride/20 mM phosphate buffer (pH 7.0) for 60 minutes, then washing the permeabilized cells with 20 mM phosphate/0.1 mM FMN buffer (pH 7.0).
- the amount of whole cell catalyst added to a reaction mixture was chosen so as to provide the necessary concentrations of glycolate oxidase and catalase activities as described above for the corresponding soluble enzymes. Recoveries of glycolate oxidase and catalase activities of greater than 100 % of their initial values are due to increased permeabilization of the cells during the course of the reaction.
- Microbial cell transformants were assayed for glycolate oxidase activity by accurately weighing ca. 5-10 mg of wet cells (blotted on filter paper to remove excess moisture) into a 3-mL quartz cuvette containing a magnetic stirring bar and 2.0 mL of a solution which was 0.12 mM in 2,6-dichlorophenol-indophenol (DCIP) and 80 mM in TRIS (tris(hydroxymethyl)aminomethane) buffer (pH 8.3).
- DCIP 2,6-dichlorophenol-indophenol
- TRIS tris(hydroxymethyl)aminomethane
- Glycolate oxidase and catalase activities of the H. polymorpha or P. pastoris wet cells (permeabilized) cultured in different media ranged from 20 to 120 DCIP IU/gram wet cells for glycolate oxidase and 30,000 to 200,000 IU/gram wet cells for endogenous catalase.
- FMN flavin mononucleotide
- concentration of added FMN is in addition to any FMN present with the enzyme, because FMN is often also added to the enzyme during the preparation of the enzyme.
- the structure of FMN and a method for its analysis is found in K. Yagai, Methods of Biochemical Analysis, Vol. X, Interscience Publishers, New York, 1962, p. 319-355.
- L-lactic acid is available commercially. In the present reaction its initial concentration is in the range of 0.10 M to 2.0 M, preferably between 0.25 M and 1.0 M. It can be employed in the reaction as the acid, or as a compatible salt thereof; that is, a salt that is water-soluble and whose cation does not interfere with the desired conversion of L-lactic acid to pyruvic acid. Suitable and compatible salt-forming cationic groups are readily determined by trial. Representative of such salts are the alkali metal, alkaline earth metal, ammonium. substituted ammonium, phosphonium, and substituted phosphonium salts. L-lactic acid produced via fermentation can be used as substrate as a filtered solution directly from the fermenter, without purification or isolation from the fermentation broth.
- the conversion of L-lactic acid to pyruvic acid is conveniently and preferably conducted in aqueous media.
- the pH of the reaction mixture is adjusted to a value between 6 and 10, preferably between 7 and 9. Within this pH range, the exact value may be adjusted to obtain the desired pH by adding any compatible, non-interfering base, including (but not limited to) alkali metal hydroxides, carbonates, bicarbonates and phosphates.
- the pH of an unbuffered reaction mixture decreases by ca. 2 pH units as the reaction proceeds, so it is often useful to start the reaction near the high end of the maximum enzyme activity pH range, about 9.0 - 8.5, and allow it to drop during the reaction; typically, the final pH of unbuffered reaction mixtures ranges from ca. 6.7 to 7.5.
- the pH can optionally be maintained by the separate addition of a non-interfering inorganic or organic buffer which has some buffering capacity around the pH of 7.5, since the optimal enzyme activity for the oxidation of L-lactate is close to this value; an initial pH of 7.5 is employed when using a suitable buffer. It is understood that L-lactic and pyruvic acid are highly dissociated in water, and that at a pH of between 7 and 10 are largely if not substantially present as L-lactate and pyruvate ions.
- Oxygen (O 2 ) the oxidant for the conversion of L-lactic acid to pyruvic acid, may be added as a gas to the reaction by agitation of the liquid at the gas-liquid interface or through a membrane permeable to oxygen.
- oxygen may be added by sparging (bubbling) oxygen or an oxygen containing gas through the reaction mixture.
- the reaction rate is at least partially controlled by the rate at which oxygen can be dissolved into the aqueous medium.
- oxygen can be added to the reaction as air, a relatively pure form of oxygen may also be used.
- oxygen pressures up to 50 x 10 5 Pa (50 atmospheres) may be used, and an upper limit of 15 x 10 5 Pa (15 atmospheres) is preferred.
- Agitation is important to maintaining a high oxygen dissolution (hence reaction) rate. Any convenient form of agitation is useful, such as stirring. High shear agitation or agitation that produces foam may decrease the activity of the soluble enzyme(s), and should be avoided when using soluble enzyme catalysts.
- the reaction temperature is an important variable, in that it affects reaction rate and the stability of the enzymes. Typically a reaction temperature of up to about 40 °C may be used without substantial loss of catalytic activity, while the preferred reaction temperature range is from about 0 °C to about 15 °C. Operating in the preferred temperature range maximizes recovered enzyme activity at the end of the reaction. The temperature should not be so low that the aqueous solution starts to freeze. Temperature can be controlled by ordinary methods, such as, but not limited to, by using a jacketed reaction vessel and passing liquid of the appropriate temperature through the jacket.
- the reaction vessel may be constructed of any material that is inert to the reaction ingredients.
- soluble enzyme catalysts may be removed by filtration or centrifugation and optionally reused. Alternatively, they can be denatured and precipitated by heating, e.g. to 70 °C for 5 minutes and/or can be allowed to remain in the reaction mixture if their presence is not objectionable. Permeabilized cell catalysts may be separated from reaction mixtures for recycle by centrifugation or filtration. Following the removal of the soluble enzyme or microbial cell catalysts, flavin mononucleotide (FMN) may optionally be removed by contacting the solution with activated carbon.
- FMN flavin mononucleotide
- the desired pyruvic acid i.e., the pyruvic acid and pyruvate salts
- the resulting solution can be concentrated and the pyruvic acid recovered by removal of water; again for example, by stripping of water under reduced pressure, lyophilization (freeze drying) or any other method as generally known in the art.
- the yields of pyruvate and acetate, and the recovered yield of L-lactate are percentages based on the total amount of L-lactic acid present at the beginning of the reaction, unless otherwise indicated. Analyses of reaction mixtures were performed using high pressure liquid chromatography (HPLC): organic acid analyses were performed using a Bio-Rad HPX-87H column.
- the vessel was then pressurized to 5.8 x 10 5 Pa (70 psig) of oxygen and the mixture stirred at 5 °C. Aliquots (0.10 mL) were removed by syringe through a sampling port (without loss of pressure in the vessel) at regular intervals for analysis by HPLC to monitor the progress of the reaction. After 28.5 hours, the HPLC yields of pyruvate and acetate were 47.7% and 43.6%, respectively, and 11.5% lactate remained. The remaining activity of glycolate oxidase and catalase were 40% and 100%, respectively, of their initial values.
- Example 2 The procedure described in Example 1 was repeated using a 10 mL aqueous solution containing L-lactic acid (96 % L-isomer, 4 % D-isomer, 0.750 M), KH 2 PO 4 (0.750 M), FMN (0.01 mM), isobutyric acid (HPLC intemal standard, 0.100 M), spinach glycolate oxidase (1.0 IU/mL), and soluble Aspergillus niger catalase (14,000 IU/mL) at pH 8.1 and at 5 °C. After 48 hours, the HPLC yields of pyruvate and acetate were 79.6 % and 3.8 %, respectively, and 20.2 % lactate remained. The remaining activities of glycolate oxidase and catalase after 18 hours of reaction were 22 % and 100 %, respectively, of their initial values.
- Example 2 The procedure described in Example 1 was repeated using a 10 mL aqueous solution containing L-lactic acid (96 % L-isomer, 4 % D-isomer, 0.500 M), KH 2 PO 4 (0.50 M), FMN (0.01 mM), isobutyric acid (HPLC internal standard, 0.100 M), spinach glycolate oxidase (2.0 IU/mL), and soluble Aspergillus niger catalase (14,000 IU/mL) at pH 8.3 and at 5 °C. After 18 hours, the HPLC yields of pyruvate and acetate were 90.5 % and 4.2 %, respectively, and 6.4 % lactate remained. The remaining activities of glycolate oxidase and catalase were 57 % and 100 %, respectively, of their initial values.
- Example 2 The procedure described in Example 1 was repeated using a 10 mL aqueous solution containing sodium L-lactate (0.500 M), isobutyric acid (HPLC internal standard, 0.100 M), spinach glycolate oxidase (2.0 IU/mL), and soluble Aspergillus niger catalase (20,000 IU/mL) at pH 9.0 (adjusted with 50 % NaOH) and at 15 °C; no buffer was added. After 7 hours, the HPLC yields of pyruvate and acetate were 91.6 % and 0.6 %, respectively, and 7.1 % lactate remained. The remaining activities of glycolate oxidase and catalase were 21 % and 100 %, respectively, of their initial values.
- Example 2 The procedure described in Example 1 was repeated using a 10 mL aqueous solution containing sodium L-lactate (0.500 M), isobutyric acid (HPLC internal standard, 0.100 M), spinach glycolate oxidase (6.0 IU/mL), and soluble Aspergillus niger catalase (10,000 IU/mL) at pH 9.0 (adjusted with 50 % NaOH) and at 15 °C; no buffer was added. After 5 hours, the HPLC yields of pyruvate and acetate were 95.3 % and 0.9 %, respectively, and 4.5 % lactate remained. The remaining activities of glycolate oxidase and catalase were 68 % and 100 %, respectively, of their initial values.
- Pichia pastoris transformant GS115-MSP10 (65.2 IU glycolate oxidase and 101,000 IU catalase) which had been permeabilized by treatment with 0.1 % benzalkonium chloride ("LONZA BARQUAT" OJ-50), then the reaction vessel was sealed and the reaction mixture was cooled to 5 °C.
- the vessel was flushed with oxygen by pressurizing to 5.8 x 10 5 Pa (70 psig) and venting to atmospheric pressure five times with stirring, then the vessel was pressurized to 5.8 x 10 5 Pa (70 psig) of oxygen and the mixture stirred at 5 °C.
- Example 6 The reaction in Example 6 was repeated using bicine buffer (0.5 M) in place of KH 2 PO 4 (0.50 M). After 5 hours, the HPLC yields of pyruvate and acetate were 93.1 % and 6.3 %, respectively, and 0.4 % lactate remained. The remaining permeabilized cell activity of glycolate oxidase and catalase were 107 % and 122 %, respectively, of their initial values.
- Example 6 The procedure described in Example 6 was repeated using 10 mL of an aqueous solution containing sodium L-lactate (0.500 M) and isobutyric acid (HPLC internal standard, 0.100 M) at pH 9.0 (adjusted with 50 % NaOH), to which was added 0.75 g of Pichia pastoris transformant GS115-MSP10 (65.2 IU glycolate oxidase and 101,000 IU catalase) which had been permeabilized by treatment with 0.1 % benzalkonium chloride ("LONZA BARQUAT" OJ-50); no buffer was added. After 5 hours, the HPLC yields of pyruvate and acetate were 99.0 % and 0.7 %, respectively, and 0.4 % lactate remained. The remaining penneabilized cell activity of glycolate oxidase and catalase were 119 % and 113 %, respectively, of their initial values.
- Example 6 The procedure described in Example 6 was repeated using 10 mL of an aqueous solution containing sodium L-lactate (0.500 M) and isobutyric acid (HPLC internal standard, 0.100 M) at pH 9.0 (adjusted with 50 % NaOH), to which was added 0.35 g of Pichia pastoris transformant GS115-MSP10 (22.6 IU glycolate oxidase and 50,000 IU catalase) which had been permeabilized by treatment with 0.1 % benzalkonium chloride ("LONZA BARQUAT" OJ-50); no buffer was added. After 8 hours, the HPLC yields of pyruvate and acetate were 97.4 % and 2.3 %, respectively, and 0.4 % lactate remained. The remaining permeabilized cell activity of glycolate oxidase and catalase were 123 % and 150 %, respectively, of their initial values.
- HPLC yields of pyruvate and acetate were 97.4 % and
- Example 6 The procedure described in Example 6 was repeated using 10 mL of an aqueous solution containing sodium L-lactate (0.500 M) and isobutyric acid (HPLC internal standard, 0.100 M) at pH 9.0 (adjusted with 50 % NaOH), to which was added 0.18 g of Pichia pastoris transformant GS115-MSP10 (11.3 IU glycolate oxidase and 25,000 IU catalase) which had been permeabilized by treatment with 0.1 % benzalkonium chloride ("LONZA BARQUAT" OJ-50); no buffer was added. After 10 hours, the HPLC yields of pyruvate and acetate were 92.9 % and 5.0 %, respectively, and 3.3 % lactate remained. The remaining permeabilized cell activity of glycolate oxidase and catalase were 121 % and 228 %, respectively, of their initial values.
- HPLC yields of pyruvate and acetate were 92.9 % and 5.0 %
- Example 6 The procedure described in Example 6 was repeated using 10 mL of an aqueous solution containing sodium L-lactate (1.00 M) and isobutyric acid (HPLC internal standard, 0.100 M) at pH 9.0 (adjusted with 50 % NaOH), to which was added 0.71 g of Pichia pastoris transformant GS115-MSP10 (45.9 IU glycolate oxidase and 100,000 IU catalase) which had been permeabilized by treatment with 0.1 % benzalkonium chloride ("LONZA BARQUAT" OJ-50); no buffer was added. After 8 hours, the HPLC yields of pyruvate and acetate were 89.1 % and 8.4 %, respectively, and 1.3 % lactate remained. The remaining permeabilized cell activity of glycolate oxidase and catalase were 124 % and 145 %, respectively, of their initial values.
- Example 6 The procedure described in Example 6 was repeated using 10 mL of an aqueous solution containing sodium L-lactate (0.50 M) and isobutyric acid (HPLC internal standard, 0.100 M) at pH 9.0 (adjusted with 50 % NaOH), to which was added 0.66 g of Pichia pastoris transformant GS115-MSP10 (62.7 IU glycolate oxidase and 100,000 IU catalase) which had been permeabilized by treatment with 0.1 % benzalkonium chloride ("LONZA BARQUAT" OJ-50); no buffer was added.
- the reaction temperature was 15 °C and the oxygen pressure was 5.8 x 10 5 Pa (70 psig).
- Example 12 The procedure described in Example 12 was repeated using 10 mL of an aqueous solution containing sodium L-lactate (0.50 M) and isobutyric acid (HPLC internal standard, 0.100 M) at pH 9.0 (adjusted with 50 % NaOH), to which was added 1.04 g of Hansenula polymorpha transformant GO1 (64.7 IU glycolate oxidase and 50,000 IU catalase) which had been permeabilized by treatment with 0.1 % benzalkonium chloride ("LONZA BARQUAT" OJ-50); no buffer was added.
- the reaction temperature was 15 °C and the oxygen pressure was 5.8 x 10 5 Pa (70 psig).
- Example 13 The reaction described in Example 13 was repeated at 5 °C and 9.3 x 10 5 Pa (120 psig) of oxygen. After 4 hours, the HPLC yields of pyruvate and acetate were 93.1 % and 3.7 %, respectively, and 2.2 % lactate remained. The remaining permeabilized cell activity of glycolate oxidase and catalase were 66 % and 180 %, respectively, of their initial values.
- Example 13 The reaction described in Example 13 was repeated at 30 °C and 5.8 x 10 5 Pa (70 psig) of oxygen. After 3 hours, the HPLC yields of pyruvate and acetate were 89.9 % and 6.5 %, respectively, and 0.6 % lactate remained. The remaining permeabilized cell activity of glycolate oxidase and catalase were 45 % and 140 %, respectively, of their initial values.
- the reactor purged with oxygen, then the mixture was stirred at 750 rpm, which bubbled oxygen through the mixture via the action of the turbine impeller, and at 5 °C under 3.8 x 10 5 Pa (40 psig) of oxygen.
- the reaction was monitored by taking a 0.40 mL aliquot of the reaction mixture at regular intervals, filtering the aliquot using a Millipore Ultrafree-MC 10,000 NMWL Filter Unit, and analyzing the filtrate by HPLC using 0.10 M isobutyric acid added to the sample as internal standard. After 3.0 hours, the HPLC yields of pyruvate and acetate were 99.2 % and 1.4 %, respectively, and 0.6 % lactate remained.
- the recovered activities of permeabilized-cell glycolate oxidase and catalase were 107 % and 106 % of their initial values, respectively.
- the reaction mixture was centrifuged to remove the permeabilized-cell catalyst, and the resulting supernatant filtered through a 0.2 mm- nylon filter.
- the pH of the resulting filtrate was adjusted to 4.6 with 1.0 N HCl, then the solution was frozen and the water removed by lyophilization to produce 5.20 g of sodium pyruvate (96 % isolated yield, 98 % sodium pyruvate as determined by HPLC analysis).
- a fermentation broth containing 109.9 g/L of ammonium lactate (97.8 % L-lactate, 2.2 % D-lactate), 0.8 g/L acetate, and 2.8 g/L maltose was centrifuged to remove particulate matter, then filtered through a 0.45 mm filter.
- the concentration of ammonium lactate in the resulting solution was 1.10 M (118-6 g/L determined by HPLC analysis).
- the reactor purged with oxygen, then the mixture was stirred at 750 rpm, which bubbled oxygen through the mixture via the action of the turbine impeller, and at 5°C under 3.8 x 10 5 Pa (40 psig) of oxygen.
- the reaction was monitored by taking a 0.40 mL aliquot of the reaction mixture at regular intervals, filtering tlie aliquot using a Millipore Ultrafree-MC 10,000 NMWL Filter Unit, and analyzing the filtrate by HPLC using 0.10 M isobutyric acid as internal standard. After 3.0 hours, the HPLC yields of pyruvate and acetate were 94.1 % (96.2 % based on L-lactate) and 2.8 %, respectively, and 2.5 %, lactate remained.
- the recovered activities of permeabilized-cell glycolate oxidase and catalase were 101 % and 56 % of their initial values, respectively.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
| catalyst | g.o. (IU/mL) | catalase (IU/mL) | reaction time (h) | pyruvate (%) | acetate (%) | lactate (%) |
| soluble enzymes | 6.0 | 10,000 | 5 | 95.3 | 4.5 | 0.9 |
| H. polymorpha | 6.4 | 5,000 | 2 | 97.0 | 2.5 | 0.4 |
| Pichia pastoris | 6.3 | 10,000 | 3 | 98.2 | 1.2 | 0.6 |
Claims (5)
- A process for the production of pyruvic acid comprising the steps of reacting, in an aqueous solution, L-lactic acid and oxygen in the presence of a permeabilized whole cell catalyst comprising an enzyme catalyst glycolate oxidase and an enzyme catalyst catalase, with or without a buffer, at a temperature from about 0°C to about 40°C, for a time sufficient to convert the L-lactic acid to pyruvic acid at high yields, wherein the initial concentration of the L-lactic acid is from about 0.1 to about 2.0 M, and then recovering the pyruvic acid.
- A process of Claim 1 wherein said enzyme catalysts are present in a microbial transformant.
- A process of Claim 1 wherein no additional buffer is added and no pH control occurs during the reaction.
- A process of Claim 1 wherein the reaction is performed at a pH of about 6 to about 10 and wherein from 0.01 to 1,000 IU/ml of glycolate oxidase activity and from 50 to 50,000 IU/ml of catalase activity are present.
- A process of Claim 3 wherein from 0.1 to 10 IU/ml of glycolate oxidase activity and from 2,000 to 15,000 IU/ml of catalase activity are present and the IU/ml ratio of catalase to glycolate oxidase activities is at least 250:1.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8287993A | 1993-06-25 | 1993-06-25 | |
| US82879 | 1993-06-25 | ||
| PCT/US1994/006436 WO1995000656A1 (en) | 1993-06-25 | 1994-06-15 | Process for the preparation of pyruvic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0705345A1 EP0705345A1 (en) | 1996-04-10 |
| EP0705345B1 true EP0705345B1 (en) | 1999-04-14 |
Family
ID=22174039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP94919409A Expired - Lifetime EP0705345B1 (en) | 1993-06-25 | 1994-06-15 | Process for the preparation of pyruvic acid |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0705345B1 (en) |
| JP (1) | JP3709202B2 (en) |
| KR (1) | KR100274552B1 (en) |
| CN (1) | CN1096500C (en) |
| AU (1) | AU686182B2 (en) |
| BR (1) | BR9407269A (en) |
| CA (1) | CA2165940C (en) |
| DE (1) | DE69417892T2 (en) |
| ES (1) | ES2132409T3 (en) |
| GR (1) | GR3030756T3 (en) |
| HU (1) | HU213759B (en) |
| NZ (1) | NZ267894A (en) |
| RU (1) | RU2123529C1 (en) |
| WO (1) | WO1995000656A1 (en) |
| ZA (1) | ZA944559B (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869301A (en) * | 1995-11-02 | 1999-02-09 | Lockhead Martin Energy Research Corporation | Method for the production of dicarboxylic acids |
| JP4367616B2 (en) | 2003-10-21 | 2009-11-18 | 日本電気株式会社 | Thermostable lactate oxidase |
| US7470813B2 (en) | 2007-03-30 | 2008-12-30 | Ge Healthcare Limited | Method for the production of pyruvic acid |
| CN106636022B (en) * | 2017-01-05 | 2020-01-07 | 江南大学 | An oxidase and its application |
| CN106591251B (en) * | 2017-01-05 | 2020-01-03 | 江南大学 | Oxidase and application thereof |
| CN106701706B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754783B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754786B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754797B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754779B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754784B (en) * | 2017-01-05 | 2019-11-26 | 江南大学 | A kind of oxidizing ferment and its application |
| CN106754780B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754778B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106591252B (en) * | 2017-01-05 | 2019-11-26 | 江南大学 | A kind of oxidizing ferment and its application |
| CN106701703B (en) * | 2017-01-05 | 2019-11-08 | 江南大学 | A kind of oxidase and its application |
| CN106754785B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754798B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754787B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754799B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754795B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN106754796B (en) * | 2017-01-05 | 2019-11-15 | 江南大学 | A kind of oxidase and its application |
| CN109988784B (en) * | 2019-04-16 | 2021-02-02 | 台州学院 | A kind of method for immobilizing glycolate oxidase catalyzing synthesis of pyruvate |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4900668A (en) * | 1987-10-01 | 1990-02-13 | Basf Aktiengesellschaft | Preparation of pyruvic acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2804079B2 (en) * | 1988-05-18 | 1998-09-24 | 協和メデックス株式会社 | Quantitative method of NAD (P) H |
-
1994
- 1994-06-15 RU RU96101052A patent/RU2123529C1/en not_active IP Right Cessation
- 1994-06-15 BR BR9407269A patent/BR9407269A/en not_active IP Right Cessation
- 1994-06-15 ES ES94919409T patent/ES2132409T3/en not_active Expired - Lifetime
- 1994-06-15 KR KR1019950705919A patent/KR100274552B1/en not_active Expired - Fee Related
- 1994-06-15 JP JP50286895A patent/JP3709202B2/en not_active Expired - Fee Related
- 1994-06-15 EP EP94919409A patent/EP0705345B1/en not_active Expired - Lifetime
- 1994-06-15 AU AU70567/94A patent/AU686182B2/en not_active Ceased
- 1994-06-15 DE DE69417892T patent/DE69417892T2/en not_active Expired - Fee Related
- 1994-06-15 NZ NZ267894A patent/NZ267894A/en unknown
- 1994-06-15 WO PCT/US1994/006436 patent/WO1995000656A1/en not_active Ceased
- 1994-06-15 HU HU9503773A patent/HU213759B/en not_active IP Right Cessation
- 1994-06-15 CN CN94192574A patent/CN1096500C/en not_active Expired - Fee Related
- 1994-06-15 CA CA002165940A patent/CA2165940C/en not_active Expired - Fee Related
- 1994-06-24 ZA ZA944559A patent/ZA944559B/en unknown
-
1999
- 1999-07-14 GR GR990401841T patent/GR3030756T3/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4900668A (en) * | 1987-10-01 | 1990-02-13 | Basf Aktiengesellschaft | Preparation of pyruvic acid |
Non-Patent Citations (4)
| Title |
|---|
| B. A. BURDICK AND J. R. SCHAEFFER: "Co-Immobilized Coupled Enzyme Systems on Nylon Mesh Capable of Gluconic and Pyruvic Acid Production.", BIOTECH. LETT., vol. 9, no. 4, pages 253 - 258 * |
| C. O. CLAGETT ET AL.: "Oxidation of alpha-Hydroxy Acids by Enzymes from <plants.", J. BIOL. CHEM., vol. 178, pages 977 - 987 * |
| K. E. RICHARDSON AND N. E. TOLBERT: "Oxidation of Glyoxylic Acid to Oxalic Acid by Glyoxylic Acid Oxidase.", J. BIOL. CHEM., vol. 236, no. 4-6, pages 1280 - 1284 * |
| N. E. TOLBERT ET AL.: "Products of the Oxidation of Glycolic Acid and l-Lactic Acid by Enzymes from Tobacco Leaves.", J. BIOL. CHEM., vol. 181, pages 905 - 914 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1125961A (en) | 1996-07-03 |
| KR100274552B1 (en) | 2000-12-15 |
| CA2165940A1 (en) | 1995-01-05 |
| JPH08511689A (en) | 1996-12-10 |
| AU7056794A (en) | 1995-01-17 |
| GR3030756T3 (en) | 1999-11-30 |
| RU2123529C1 (en) | 1998-12-20 |
| JP3709202B2 (en) | 2005-10-26 |
| HU9503773D0 (en) | 1996-02-28 |
| HU213759B (en) | 1997-09-29 |
| HUT74223A (en) | 1996-11-28 |
| ES2132409T3 (en) | 1999-08-16 |
| CN1096500C (en) | 2002-12-18 |
| NZ267894A (en) | 1997-10-24 |
| WO1995000656A1 (en) | 1995-01-05 |
| DE69417892T2 (en) | 1999-10-14 |
| CA2165940C (en) | 2005-09-13 |
| EP0705345A1 (en) | 1996-04-10 |
| ZA944559B (en) | 1995-12-27 |
| AU686182B2 (en) | 1998-02-05 |
| DE69417892D1 (en) | 1999-05-20 |
| BR9407269A (en) | 1996-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0705345B1 (en) | Process for the preparation of pyruvic acid | |
| WO1996035800A1 (en) | Enzymatic production of gluconic acid or its salts | |
| Eisenberg et al. | Pyruvic acid production using methylotrophic yeast transformants as catalyst | |
| EP0621900B1 (en) | Oxidation of glycolic acid to glyoxylic acid using a microbial cell transformant as catalyst | |
| US5538875A (en) | Process for the preparation of pyruvic acid using permeabilized transformants of H. polymorha and P. pastoris which express glycolate oxidase and catalase | |
| US5541094A (en) | Glyoxylic acid/aminomethylphosphonic acid mixtures prepared using a microbial transformant | |
| EP0384534B1 (en) | A process for the fermentative oxidation of reducing disaccharides | |
| EP0496799B1 (en) | Production of glyoxylic acid by enzymatic oxidation of glycolic acid | |
| US5135860A (en) | Process for preparing glyoxylic acid/aminomethylphosphonic acid mixtures | |
| EP0545553B1 (en) | Enzymatic preparation of N-(phosphonomethyl)glycine | |
| US5559020A (en) | Process for preparing glyoxylic acid/dialkyl aminomethylphosphonate mixtures | |
| EP0706577B1 (en) | An improved method of preparing glyoxylic acid/aminomethylphosphonic acid mixtures using a microbial double-transformant | |
| AU7316194A (en) | Glyoxylic acid/aminomethylphosphonic acid mixtures prepared using a microbial transformant | |
| CN1153532A (en) | Glyoxylic acid/aminomethylphosphonic acid mixtures prepared using microbial transformant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19951130 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE ES FR GB GR IT |
|
| 17Q | First examination report despatched |
Effective date: 19970917 |
|
| GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
| GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE ES FR GB GR IT |
|
| REF | Corresponds to: |
Ref document number: 69417892 Country of ref document: DE Date of ref document: 19990520 |
|
| ET | Fr: translation filed | ||
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2132409 Country of ref document: ES Kind code of ref document: T3 |
|
| RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: UNIVERSITY OF IOWA RESEARCH FOUNDATION |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed | ||
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20080625 Year of fee payment: 15 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20080717 Year of fee payment: 15 Ref country code: DE Payment date: 20080619 Year of fee payment: 15 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20080617 Year of fee payment: 15 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20080618 Year of fee payment: 15 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20080515 Year of fee payment: 15 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20090615 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20100226 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090630 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090615 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100101 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20090616 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100107 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090616 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090615 |